Gene expression data from T47D human breast ductal carcinoma cells treated with prolactin and/or NIM811

ABSTRACT: The hormone prolactin is implicated in the pathogenesis of breast cancer, and a subset of prolactin-induced gene expression is mediated by CypA activity. The non-immunosuppressive prolyl isomerase inhibitor, NIM811, is an inhibitor of CypA. We used NIM811 in combination with prolactin treatment in T47D cells to determine differential expression under these conditions.

ORGANISM(S): Homo sapiens

PROVIDER: GSE151635 | GEO | 2020/06/03

REPOSITORIES: GEO